Myofascial Pain Dysfunction Syndrome
11
2
2
3
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
0.0%
0 terminated out of 11 trials
100.0%
+13.5% vs benchmark
9%
1 trials in Phase 3/4
0%
0 of 3 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 3 completed trials
Clinical Trials (11)
Evaluation of the Effect of Adding Sodium Bicarbonate to Lidocaine in the Treatment of Myofascial Pain Syndrome
PRP vs PRP+Betamethasone vs Betamethasone Injection for Upper Trapezius Myofascial Pain
Comparative Effectiveness of Standard and Modified Laser Therapy in Myofascial Pain Management.
Bruxism, Pelvic Pain, Erectile Dysfunction, and Anxiety in Young Adult Men
Bruxism and Pelvic Floor Dysfunction in Young Women
Comparison of Treatment Modalities in Myofascial Pain Syndrome
Magnesium Sulfate as an Adjuvant to Lidocaine in MPDS Trigger Point Injections Assessed by VAS and sEMG.
Validity, Reliability of Neck Disability Index in Albanian
Lidocaine Versus Magnesium Sulphate in Management of Myofascial Pain Dysfunction Syndrome
Yoga-Based Exercise Program For Temporomandibular Disorders
Brief Treatment for Temporomandibular Pain